Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Lavigne, Jean Philippe ^a,b,c   Vergunst, Annette C ^a,b   Goret, Lucie ^a,b   Sotto, Albert ^a,b   Combescure, Christophe ^d   Blanco, Jorge ^e   O'Callaghan, David ^a,b   Nicolas Chanoine, Marie Hélène ^a,f,g  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^f BEAUJON HOSPITAL   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CAENORHABDITIS ELEGANS; CLONE; CONTROLLED STUDY; EMBRYO; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE MAPPING; NONHUMAN; PHYLOGENETIC TREE; STRAIN DIFFERENCE; UROPATHOGENIC ESCHERICHIA COLI; ZEBRA FISH; GENETICS; PATHOGENICITY; VIROLOGY; VIRULENCE;

ANIMALIA; CAENORHABDITIS ELEGANS; DANIO RERIO; ESCHERICHIA COLI;

ESCHERICHIA COLI; GENOME, BACTERIAL; VIRULENCE;

EID: 84858775420     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034294     Document Type: Article

References (39)

1. Foxman B, (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49: 53-70.
2. Elkharrat D, Arrouy L, Benhamou F, et al. (2007) [Epidemiology of community urinary tract infection in adults in France]. Monog Urol pp. 1-20.
3. Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, et al. (2011) Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill 16: 19819.
4. Canton R, Coque TM, (2006) The CTX-M β-lactamase pandemic. Curr Opin Microbiol 9: 466-475.
5. Arpin C, Coulange L, Dubois V, André C, Fisher I, et al. (2007) Extended-Spectrum β-lactamase-producing Enterobacteriaceae in various types of private health care centers. Antimicrob Agents Chemother 51: 3440-3444.
6. Lavigne JP, Marchandin H, Delmas J, Moreau J, Bouziges N, et al. (2007) CTX-M β-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors. J Clin Microbiol 45: 620-626.
7. Pitout JD, Gregson DB, Church DL, Elsayed S, Laupland KB, (2005) Community-wide outbreaks of clonally related CTX-M-14 β-lactamase-producing Escherichia coli strains in the Calgary health region. J Clin Microbiol 43: 2844-2849.
8. Pitout JD, Nordmann P, Laupland KB, Poirel L, (2005) Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 56: 52-59.
9. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, et al. (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273-281.
10. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, et al. (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 14: 195-200.
11. Rogers BA, Sidjabat HE, Paterson DL, (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66: 1-14.
12. Uchida Y, Mochimaru T, Morokuma Y, Kiyosuke M, Fujise M, et al. (2010) Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors. Int J Antimicrob Agents 35: 444-450.
13. Cerquetti M, Giufrè M, García-Fernández A, Accogli M, Fortini D, et al. (2010) Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy. Clin Microbiol Infect 16: 1555-1558.
14. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, et al. (2008) Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 46: 3900-3905.
15. Johnson JR, Clermont O, Menard M, Kuskowski MA, Picard B, et al. (2006) Experimental Mouse Lethality of Escherichia coli Isolates, in Relation to Accessory Traits, Phylogenetic Group, and Ecological Source. J Infect Dis 194: 1141-1150.
16. Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, et al. (2007) Extraintestinal virulence is a coincidental by product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol 24: 2373-2384.
17. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, et al. (2008) The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61: 1024-1028.
18. Wiles TJ, Bower JM, Redd MJ, Mulvey MA, (2009) Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. PLoS Pathog 5: e1000697.
19. Lavigne JP, Blanc-Potard AB, Bourg G, Moreau J, Chanal C, et al. (2006) Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases. Clin Microbiol Infect 12: 1199-1206.
20. Brzuszkiewicz E, Brüggemann H, Liesegang H, Emmerth M, Ölschläger T, et al. (2006) How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 103: 12879-12884.
21. Tourret J, Diard M, Garry L, Matic I, Denamur E, (2010) Effects of single and multiple pathogenicity island deletions on uropathogenic Escherichia coli strain 536 intrinsic extra-intestinal virulence. Int J Med Microbiol 300: 435-439.
22. Vergunst AC, Meijer AH, Renshaw SA, O'Callaghan, (2010) Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect Immun 78: 1495-1508.
23. Avasthi TS, Kumar N, Baddam R, Hussain A, Nandanwar N, Jadhav S, Ahmed N, (2011) Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J Bacteriol 193: 4272-4273.
24. O'Callaghan D, Vergunst A, (2010) Non-mammalian animal models to study infectious disease: worms or fly fishing? Curr Opin Microbiol 13: 79-85.
25. Diard M, Baeriswyl S, Clermont O, Gouriou S, Picard B, et al. (2007) Caenorhabditis elegans as a simple model to study phenotypic and genetic virulence determinants of extraintestinal pathogenic Escherichia coli. Microbes Infect 9: 214-223.
26. Bialek S, Lavigne JP, Chevalier J, Marcon E, Leflon-Guibout V, et al. (2010) Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model. Antimicrob Agents Chemother 54: 4373-4378.
27. Lemonnier M, Landraud L, Lemichez E, (2007) Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol Rev 31: 515-534.
28. Davis JM, Carvalho HM, Rasmussen SB, O'Brien AD, (2006) Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect Immun 74: 4401-4408.
29. Davis JM, Rasmussen SB, O'Brien AD, (2005) Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function. Infect Immun 73: 5301-5310.
30. Bauer ME, Welch RA, (1996) Association of RTX toxins with erythrocytes. Infect Immun 64: 4665-4672.
31. Capo C, Meconi S, Sanguedolce MV, Bardin N, Flatau G, et al. (1998) Effect of cytotoxic necrotizing factor-1 on actin cytoskeleton in human monocytes: role in the regulation of integrin-dependent phagocytosis. J Immunol 161: 4301-4308.
32. Schwan WR, Briska A, Stahl B, Wagner TK, Zentz E, et al. (2010) Use of optical mapping to sort uropathogenic Escherichia coli strains into distinct subgroups. Microbiology 156: 2124-2135.
33. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M, (2010) Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51: 286-294.
34. Platell JL, Johnson JR, Cobbold RN, Trott DJ, (2011) Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol 153: 99-108.
35. Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, et al. (2011) Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis 17: 1216-1222.
36. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, et al. (2009) Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53: 2733-2739.
37. Lavigne JP, Nicolas-Chanoine MH, Bourg G, Moreau J, Sotto A, (2008) Virulent synergistic effect between Enterococcus faecalis and Escherichia coli assayed by using the Caenorhabditis elegans model. PLoS One 3: e3370.
38. Garsin DA, Sifri CD, Mylonakis E, Qin X, Singh KV, et al. (2001) A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci USA 98: 10892-10897.
39. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, et al. (2011) Prospective genomic characterization of the German Enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One 6: e22751.